Home Could wearables and social media be the future of medical trials?

Could wearables and social media be the future of medical trials?

Wearables and social media might dominate the future of medical trials, according to a new survey that asked members of the Association of Clinical Research Organizations (ACRO) what technologies would be most beneficial and see the most adoption in the next two to five years.

The survey results showed five emerging technologies that are substantially beneficial and could see a substantial increase in adoption over the time period: risk-based monitoring, eConsent, wearables, social media, and real-time analytics.


See Also: Will smart pills help remind patients to take their medicine?

ACRO will use the survey results to push the Food & Drug Administration (FDA) to provide further guidance and outline the “do’s and don’ts” for professionals looking to utilize these technologies.

The FDA has already provided guidance and regulation on risk-based monitoring and eConsent.
It hasn’t given a lot of guidance on data capture, monitoring, and privacy for wearables, but consumer wearables like the Apple Watch and Fitbit are underwhelming in the health department supposedly because of FDA obstruction. That might hint that the FDA does not want some wearables tracking health data, though health-focused wearables might avoid this regulation.

Social media also playing a bigger role

Social media is another area where the FDA has been largely absent from the discussion, making medical professionals nervous to converse with patients online and offer medical guidance. A lot of ACRO members don’t seem too invested in social media as a way to track patients — that was noted as one of the least beneficial emerging technologies.

Real-time analysis is already being adopted in medical trials across America, as a way to get more data from patients. ACRO still wants more FDA guidance in this field, to avoid issues with privacy, security, and storage of private information.

It’s clear that while the medical industry moves very slow, professionals are looking at emerging technologies as way to make their jobs easier and help patients gain more benefits outside of the usual checkup. ACRO even mentions in its letter to the FDA that acceleration in this industry would happen much quicker if the FDA was able to give instruction and information on what is allowed and what is not.

About ReadWrite’s Editorial Process

The ReadWrite Editorial policy involves closely monitoring the tech industry for major developments, new product launches, AI breakthroughs, video game releases and other newsworthy events. Editors assign relevant stories to staff writers or freelance contributors with expertise in each particular topic area. Before publication, articles go through a rigorous round of editing for accuracy, clarity, and to ensure adherence to ReadWrite's style guidelines.

Get the biggest tech headlines of the day delivered to your inbox

    By signing up, you agree to our Terms and Privacy Policy. Unsubscribe anytime.

    Tech News

    Explore the latest in tech with our Tech News. We cut through the noise for concise, relevant updates, keeping you informed about the rapidly evolving tech landscape with curated content that separates signal from noise.

    In-Depth Tech Stories

    Explore tech impact in In-Depth Stories. Narrative data journalism offers comprehensive analyses, revealing stories behind data. Understand industry trends for a deeper perspective on tech's intricate relationships with society.

    Expert Reviews

    Empower decisions with Expert Reviews, merging industry expertise and insightful analysis. Delve into tech intricacies, get the best deals, and stay ahead with our trustworthy guide to navigating the ever-changing tech market.